This announcement is a separate document:
青海春天关于再次延期回复上海证券交易所《关于青海春天2023年年度报告的信息披露监管问询函》的公告
Announcement from Qinghai Spring Medicinal Resources Technology regarding the response to the regulatory inquiry letter on information disclosure for the 2023 annual report of Qinghai Spring issued by Shanghai Stock Exchange, which has been extended again.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated